以往的研究表明大约25% - 30%的患者会发生移植后的白血病复发。
Previous research studies have also shown that about 25 to 30 percent of patients suffer leukemia relapse after transplant.
结论：(1)供者白细胞的输注能使某些BMT后慢性粒细胞性白血病遗传学及血液学复发患者完全缓解。
Conclusion: (1) Donor derived leukocyte infusion can induce CML post BMT to cytogenetic and hematological CR. It has also therapeutic effects on acute leukemia relapse but is less sustained.
白血病、癌症患者在短期内得到救治，提高自身免疫功能，度过高危复发期。
Leukemia, cancer patients have been treated in the short term to improve their immune function, through high-risk relapse period.
有些患者治疗后疾病症状有所缓解，但之后ALL细胞会重新出现，这被称为复发急性淋巴细胞白血病。
Some patients have a remission after treatment but then ALL-cells return later-this is called a relapse.
方法：5 8例血液恶性肿瘤患者，33例为高危或难治复发白血病，接受了至少一个HLA位点不合的家庭供者造血干细胞移植。
Methods: In this pilot study, 58 patients, 33 with high-risk or advanced leukemia, were transplanted with cells from an HLA-haploidentical family donor with at least 1 of 6 loci mismatched.
方法：5 8例血液恶性肿瘤患者，33例为高危或难治复发白血病，接受了至少一个HLA位点不合的家庭供者造血干细胞移植。
Methods: In this pilot study, 58 patients, 33 with high-risk or advanced leukemia, were transplanted with cells from an HLA-haploidentical family donor with at least 1 of 6 loci mismatched.
应用推荐